We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Home
Services
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
US private equity investor Battery Ventures acquired Swiss-based SaaS startup Avrios International AG.
Innov Ad N.V., a leading provider of animal nutrition and health solutions, acquired its Swiss competitor Herbonis AG and its subsidiaries in Switzerland, France and the UK. Herbonis specializes in producing natural solutions for...
On 2 May 2023, Suixx sold the db electronic Group to NCAB Group, which is listed on Nasdaq Stockholm.
A group of investors advised by Munich-based Rigeto Unternehmerkapital GmbH ("Rigeto") has acquired prevention-center as an add-on to the Matignon Group.
VISCHER advised Mosanna Therapeutics AG in closing an extension of the Seed Financing Round with Supermoon Capital and High-Tech Gründerfonds.
VISCHER successfully fended off, on behalf of one of its clients, an extensive and far-reaching application for interim relief sought in the framework of Emergency Arbitration proceedings under the ICC Rules.
The shareholders of the Mimacom Flowable Group ("MFG") have sold MFG to the private equity investment house Ardian, accompanied by a reinvestment of the management. The transaction was completed on 19 April 2023. Headquartered in...
ATANIS Biotech AG, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase.
Intel Capital, a leading investor in the future of compute, has invested in UNISERS AG, a Swiss semiconductor metrology company that identifies invisible contamination-caused defects in semiconductor materials. The USD14m seed financing round was led by Intel Capital, with participation from M Ventures, RSBG Ventures and Swisscom Ventures.
Bachem Holding AG (SIX:BANB) has raised a total of CHF 108.1 million through an accelerated bookbuilding process by issuing 1,250,000 new shares at a placement price of CHF 86.50 per share to accelerate its growth plans.
Displaying results 1 to 10 out of 461
